EP1203585A4 - Agent anti-ischemique - Google Patents

Agent anti-ischemique

Info

Publication number: EP1203585A4
Authority: EP; European Patent Office
Prior art keywords: activity; drug; ischemic; obzidan; ischemic agent
Prior art date: 1999-07-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP00937410A

Other languages

German (de)

English (en)

Other versions

EP1203585A1 (fr

EP1203585B1 (fr

Inventor

Ivan Nikolaevich Tjurenkov

Valentina Mikh Berestovitskaya

Maya Mikhailovna Zobacheva

Olga Sergeevna Vasileva

Nina Vladimirovna Usik

Boris Mikhailovich Novikov

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Zakrytoe Aktsionernoe Obschestvo "asgl-Issledovate

Original Assignee

ZAKRYTOE AKTSIONERNOE OBSCHESTVO "ASGL-ISSLEDOVATELSKIE LABORATORII"

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-21

Filing date

2000-06-08

Publication date

2004-02-04

2000-06-08 Application filed by ZAKRYTOE AKTSIONERNOE OBSCHESTVO "ASGL-ISSLEDOVATELSKIE LABORATORII" filed Critical ZAKRYTOE AKTSIONERNOE OBSCHESTVO "ASGL-ISSLEDOVATELSKIE LABORATORII"

2002-05-08 Publication of EP1203585A1 publication Critical patent/EP1203585A1/fr

2004-02-04 Publication of EP1203585A4 publication Critical patent/EP1203585A4/fr

2005-03-16 Application granted granted Critical

2005-03-16 Publication of EP1203585B1 publication Critical patent/EP1203585B1/fr

2020-06-08 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP00937410A 1999-07-21 2000-06-08 Agent anti-ischemique Expired - Lifetime EP1203585B1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EA870008		1999-07-21
EA199900878A EA002380B1 (ru)	1999-07-21	1999-07-21	Антиишемическое средство
PCT/RU2000/000222 WO2001005399A1 (fr)	1999-07-21	2000-06-08	Agent anti-ischemique

Publications (3)

Publication Number	Publication Date
EP1203585A1 EP1203585A1 (fr)	2002-05-08
EP1203585A4 true EP1203585A4 (fr)	2004-02-04
EP1203585B1 EP1203585B1 (fr)	2005-03-16

Family

ID=8161511

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00937410A Expired - Lifetime EP1203585B1 (fr)	1999-07-21	2000-06-08	Agent anti-ischemique

Country Status (6)

Country	Link
EP (1)	EP1203585B1 (fr)
JP (1)	JP2003504404A (fr)
AT (1)	ATE290909T1 (fr)
DE (1)	DE60018759D1 (fr)
EA (1)	EA002380B1 (fr)
WO (1)	WO2001005399A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2213562C2 (ru) *	2001-03-14	2003-10-10	Научно-исследовательский институт фармакологии РАМН	Лекарственная композиция
RU2232578C1 (ru) *	2003-04-10	2004-07-20	Ахапкина Валентина Ивановна	Вещество, обладающее антидепрессивной активностью
RU2329804C2 (ru)	2006-03-28	2008-07-27	Валентина Ивановна Ахапкина	Вещество, обладающее нейротропной - нейромодуляторной активностью
RU2480214C1 (ru) *	2011-09-22	2013-04-27	Валентина Ивановна Ахапкина	Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2361882A1 (fr) *	1976-02-11	1978-03-17	Chemisches Lab F W Lang	Hydrazides d'acide (2-oxo-pyrrolidino-1)-acetique, procedes pour leur obtention et leur traitement ulterieur et preparations pharmaceutiques qui les contiennent
EP0363489A1 (fr) *	1988-04-18	1990-04-18	2-i MOSKOVSKY GOSUDARSTVENNY MEDITSINSKY INSTITUT IMENI N.I. PIROGOVA	Procede pour obtenir un amide de 4-phenyl-2-pyrrolidone-1-acide acetique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1141287B (it) *	1979-06-13	1986-10-01	Nattermann A & Cie	Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
GB8412357D0 (en) *	1984-05-15	1984-06-20	Ucb Sa	Pharmaceutical composition
BG49409A1 (en) *	1988-08-15	1991-11-15	Republ N Prakticheski I T Za S	Means for food therapy
RU2050851C1 (ru) *	1990-08-28	1995-12-27	Институт медико-биологических проблем	Вещество, проявляющее ноотропную активность
DE69408373T2 (de) *	1993-06-01	1998-07-16	Ono Pharmaceutical Co	Pentansäurederivate

1999
- 1999-07-21 EA EA199900878A patent/EA002380B1/ru not_active IP Right Cessation
2000
- 2000-06-08 AT AT00937410T patent/ATE290909T1/de not_active IP Right Cessation
- 2000-06-08 DE DE60018759T patent/DE60018759D1/de not_active Expired - Lifetime
- 2000-06-08 JP JP2001510456A patent/JP2003504404A/ja active Pending
- 2000-06-08 WO PCT/RU2000/000222 patent/WO2001005399A1/fr not_active Ceased
- 2000-06-08 EP EP00937410A patent/EP1203585B1/fr not_active Expired - Lifetime

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2361882A1 (fr) *	1976-02-11	1978-03-17	Chemisches Lab F W Lang	Hydrazides d'acide (2-oxo-pyrrolidino-1)-acetique, procedes pour leur obtention et leur traitement ulterieur et preparations pharmaceutiques qui les contiennent
EP0363489A1 (fr) *	1988-04-18	1990-04-18	2-i MOSKOVSKY GOSUDARSTVENNY MEDITSINSKY INSTITUT IMENI N.I. PIROGOVA	Procede pour obtenir un amide de 4-phenyl-2-pyrrolidone-1-acide acetique

Also Published As

Publication number	Publication date
JP2003504404A (ja)	2003-02-04
EP1203585A1 (fr)	2002-05-08
EA002380B1 (ru)	2002-04-25
WO2001005399A1 (fr)	2001-01-25
EP1203585B1 (fr)	2005-03-16
ATE290909T1 (de)	2005-04-15
DE60018759D1 (de)	2005-04-21
EA199900878A1 (ru)	2001-02-26

Publication	Publication Date	Title
DE3382641D1 (de)	1992-12-17	Arzneimittel fuer die therapeutische behandlung von alopezie.
MY127980A (en)	2007-01-31	A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
CY1105707T1 (el)	2010-12-22	Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
BR9811825A (pt)	2000-08-15	Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
IL195723A (en)	2010-12-30	Use of p53 inhibitors for the preparation of medicament
EA200300046A1 (ru)	2003-10-30	Быстро увеличивающаяся в объеме композиция для удерживания и контролированного выделения терапевтических агентов в желудке и лекарственные формы, включающие композицию
BR9714363A (pt)	2000-03-21	Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
MA27037A1 (fr)	2004-12-20	Amides d'acide anthranilique avec une chaine laterale heteroarylsulfonyle, procede pour leur fabrication, leur utilisation comme medicament et comme agent de diagnostic ainsi que les preparations pharmaceutiques en contenant
MX9708800A (es)	1998-02-28	Compuestos biciclicos aromaticos.
DK0668077T3 (da)	2001-10-08	Produkter, som indeholder G-CSF og TNF-bindende protein
TW197423B (fr)	1993-01-01
RU99115515A (ru)	2001-04-27	Средство для коррекции кроветворения и профилактики диспепсии новорожденных телят
ATE289805T1 (de)	2005-03-15	Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
EP1203585A4 (fr)	2004-02-04	Agent anti-ischemique
NL187299C (nl)	1991-08-16	Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten.
EP1595536A4 (fr)	2007-07-18	Preparations pharmaceutiques dont la shikonine est le principe actif
DK0559145T3 (da)	2000-04-10	Lægemiddel til truende abort
BR0008703A (pt)	2002-02-13	Utilização da tianeptina para a obtenção de medicamentos destinados ao tratamento das patologias da neurodegenerescência
RU95110494A (ru)	1997-05-27	Средство с регулируемым высвобождением пентоксифиллина для лечения сосудистых заболеваний
ATE331523T1 (de)	2006-07-15	Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATE255890T1 (de)	2003-12-15	Pantothensäure-enthaltende arzneimittel zur behandlung von entzündlichen gelenkserkrankungen
CA2469702A1 (fr)	2003-06-26	Utilisation de la darifenacine dans le traitement de mictions imperieuses induites par une vessie hyperactive
PT1572686E (pt)	2009-07-14	Derivados de amida do ácido antranílico e suas utilizações farmacêuticas
HUP0102116A2 (hu)	2002-05-29	Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
DE60202299D1 (de)	2005-01-20	Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten

Legal Events

Date	Code	Title	Description
2002-03-22	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-05-08	17P	Request for examination filed	Effective date: 20020221
2002-05-08	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-10-09	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: ZAKRYTOE AKTSIONERNOE OBSCHESTVO "ASGL-ISSLEDOVATE
2004-02-04	A4	Supplementary search report drawn up and despatched	Effective date: 20031219
2004-02-04	RIC1	Information provided on ipc code assigned before grant	Ipc: 7A 61K 31/4015 B Ipc: 7A 61P 9/10 A
2004-07-02	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2004-09-10	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2005-01-28	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2005-03-16	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2005-03-16	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050316 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050316 Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050316 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050316 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050316 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050316 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050316
2005-03-16	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2005-03-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2005-04-20	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2005-04-21	REF	Corresponds to:	Ref document number: 60018759 Country of ref document: DE Date of ref document: 20050421 Kind code of ref document: P
2005-06-08	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050608 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050608 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050608
2005-06-16	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050616 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050616 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050616
2005-06-17	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050617
2005-06-27	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050627
2005-06-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050630
2005-09-01	NLV1	Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
2005-09-07	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050907
2005-09-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2006-01-20	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2006-01-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2006-03-01	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20050616
2006-03-08	26N	No opposition filed	Effective date: 20051219
2006-03-22	REG	Reference to a national code	Ref country code: IE Ref legal event code: MM4A
2006-05-12	EN	Fr: translation not filed
2008-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050616
2008-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050630
2008-11-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050316